ClariVest Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12
| Closed | -$1K | – | 754 |
|
|
2023
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 575 |
|
|
2023
Q1 | $1K | Sell |
12
-1
| -8% | -$87 | ﹤0.01% | 608 |
|
|
2022
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 587 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 569 |
|
|
2022
Q2 | $1K | Buy |
+13
| New | +$1.66K | ﹤0.01% | 580 |
|
|
2022
Q1 | – | Sell |
-1,621
| Closed | -$262K | – | 701 |
|
|
2021
Q4 | $262K | Hold |
1,621
| – | – | 0.01% | 472 |
|
|
2021
Q3 | $242K | Hold |
1,621
| – | – | 0.01% | 476 |
|
|
2021
Q2 | $397K | Sell |
1,621
-17,290
| -91% | -$4.54M | 0.01% | 451 |
|
|
2021
Q1 | $5.01M | Sell |
18,911
-201
| -1% | -$56.7K | 0.18% | 112 |
|
|
2020
Q4 | $5.61M | Buy |
19,112
+1,100
| +6% | +$282K | 0.19% | 93 |
|
|
2020
Q3 | $4.26M | Sell |
18,012
-178
| -1% | -$40.5K | 0.14% | 123 |
|
|
2020
Q2 | $3.61M | Sell |
18,190
-10,719
| -37% | -$2M | 0.1% | 154 |
|
|
2020
Q1 | $5.31M | Sell |
28,909
-7,932
| -22% | -$1.41M | 0.16% | 101 |
|
|
2019
Q4 | $6.15M | Sell |
36,841
-11,562
| -24% | -$1.72M | 0.14% | 124 |
|
|
2019
Q3 | $6.34M | Sell |
48,403
-46,358
| -49% | -$6.03M | 0.14% | 142 |
|
|
2019
Q2 | $11.5M | Sell |
94,761
-600
| -0.6% | -$71.2K | 0.26% | 96 |
|
|
2019
Q1 | $11.8M | Sell |
95,361
-5,239
| -5% | -$658K | 0.24% | 95 |
|
|
2018
Q4 | $11.8M | Buy |
100,600
+31,258
| +45% | +$3.68M | 0.25% | 86 |
|
|
2018
Q3 | $8.66M | Sell |
69,342
-1,027
| -1% | -$113K | 0.15% | 108 |
|
|
2018
Q2 | $6.01M | Sell |
70,369
-6,711
| -9% | -$493K | 0.1% | 158 |
|
|
2018
Q1 | $4.65M | Buy |
77,080
+200
| +0.3% | +$11.4K | 0.08% | 201 |
|
|
2017
Q4 | $4.05M | Buy |
+76,880
| New | +$4.05M | 0.07% | 217 |
|
|
2016
Q4 | – | Sell |
-25
| Closed | -$1K | – | 660 |
|
|
2016
Q3 | $1K | Sell |
25
-52,897
| -100% | -$2.64M | ﹤0.01% | 628 |
|
|
2016
Q2 | $2.67M | Sell |
52,922
-3,213
| -6% | -$162K | 0.08% | 158 |
|
|
2016
Q1 | $2.71M | Buy |
56,135
+2,253
| +4% | +$86.9K | 0.08% | 150 |
|
|
2015
Q4 | $2.12M | Sell |
53,882
-8,237
| -13% | -$329K | 0.06% | 180 |
|
|
2015
Q3 | $2.36M | Buy |
62,119
+52,419
| +540% | +$2.21M | 0.07% | 174 |
|
|
2015
Q2 | $385K | Hold |
9,700
| – | – | 0.01% | 347 |
|
|
2015
Q1 | $260K | Hold |
9,700
| – | – | 0.01% | 380 |
|
|
2014
Q4 | $285K | Buy |
+9,700
| New | +$240K | 0.01% | 307 |
|
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
ClariVest Asset Management's AMED Position: Q3 2023 in Review
ClariVest Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 12 shares — an estimated $1K sold.
ClariVest Asset Management first reported a position in AMED in Q4 2014 and held it in 30 quarters. The position peaked at $11.8M in Q4 2018. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- ClariVest Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- ClariVest Asset Management sold 12 Amedisys shares in Q3 2023, an estimated $1K.
- ClariVest Asset Management first reported a position in Amedisys in Q4 2014 and held it in 30 quarters.
- ClariVest Asset Management's Amedisys position peaked at $11.8M in Q4 2018.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on ClariVest Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.